NCT04472533View on ClinicalTrials.gov

Serum Bio-markers in Pulmonary Hypertension

CompletedOBSERVATIONAL
Enrollment

377

Participants

Timeline

Start Date

April 4, 2012

Primary Completion Date

August 31, 2017

Study Completion Date

October 26, 2017

Conditions
Pulmonary Hypertension, Primary, 4
Trial Locations (1)

CB2 0AY

Royal Papworth Hospital NHS Foundation Trust, Cambridge

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Papworth Hospital NHS Foundation Trust

OTHER_GOV

NCT04472533 - Serum Bio-markers in Pulmonary Hypertension | Biotech Hunter | Biotech Hunter